cholestyramine resin has been researched along with Diabetes Mellitus, Adult-Onset in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Han, A; Liu, Q; Lu, J; Qin, Y; Sun, Q; Wang, Q; Xiang, Q; Xu, H; Yang, P; Yang, Q | 1 |
| Acikgoz, SB; Kara, RO; Kosem, M; Solak, B | 1 |
| Matsumoto, K; Yokoyama, S | 1 |
| Handelsman, Y | 1 |
| Brufau, G; Groen, AK; Out, C | 1 |
| Abaterusso, C; Abhyankar, A; Brocco, E; Carraro, A; Faedda, R; Luthman, H; Morgia, G; Nosadini, R; Satta, A; Tonolo, G; Velussi, M | 1 |
| Babaya, N; Fujisawa, T; Hiromine, Y; Ikegami, H; Itoi-Babaya, M; Kawabata, Y; Kobayashi, M; Nojima, K; Noso, S; Ogihara, T; Shibata, M; Yamaji, K | 1 |
| Kuipers, F; Staels, B | 1 |
| Garg, A; Grundy, SM | 1 |
| Florkowski, CM; Scott, RS | 1 |
| Barter, PJ; Rye, KA | 1 |
| Angius, MF; Brizzi, P; Carboni, A; Cherchi, GM; Ciccarese, M; Formato, M; Maioli, M; Melis, MG; Tonolo, G | 1 |
| Eggers, R; Farker, K; Haerting, J; Hoffmann, A; Madani, SF; Merkel, U; Müller, UA; Schweer, H; Seyberth, HW | 1 |
| Hansen, CT; Turley, SD | 1 |
5 review(s) available for cholestyramine resin and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Role of bile acid sequestrants in the treatment of type 2 diabetes.
Topics: Allylamine; Bile Acids and Salts; Cholestyramine Resin; Colesevelam Hydrochloride; Colestipol; Diabetes Mellitus, Type 2; Epichlorohydrin; Hypolipidemic Agents; Imidazoles; Resins, Synthetic | 2011 |
Bile acid sequestrants: more than simple resins.
Topics: Animals; Anion Exchange Resins; Anticholesteremic Agents; Bile Acids and Salts; Cholestyramine Resin; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dyslipidemias; Energy Metabolism; Humans | 2012 |
Bile acid sequestrants and the treatment of type 2 diabetes mellitus.
Topics: Allylamine; Animals; Bile Acids and Salts; Cholestyramine Resin; Clinical Trials as Topic; Colesevelam Hydrochloride; Colestipol; Diabetes Mellitus, Type 2; DNA-Binding Proteins; Glucose; Glycated Hemoglobin; Humans; Hypolipidemic Agents; Lipid Metabolism; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2007 |
Noninsulin dependent diabetes mellitus: the importance of dyslipidaemia.
Topics: Cholestyramine Resin; Colestipol; Contraindications; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hyperlipidemias; Hypertriglyceridemia; Hypolipidemic Agents | 1994 |
High density lipoproteins and coronary heart disease.
Topics: Animals; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoprotein A-II; Arteriosclerosis; Cholesterol, HDL; Cholestyramine Resin; Clinical Trials as Topic; Comorbidity; Coronary Disease; Diabetes Mellitus, Type 2; Gene Expression; Humans; Hyperlipidemias; Lipoproteins, HDL; Mice; Mice, Transgenic; Risk Factors | 1996 |
4 trial(s) available for cholestyramine resin and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Simvastatin maintains steady patterns of GFR and improves AER and expression of slit diaphragm proteins in type II diabetes.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Albumins; Albuminuria; Anticholesteremic Agents; Cholestyramine Resin; Deoxyguanosine; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Humans; Kidney Glomerulus; Lipids; Male; Middle Aged; Podocytes; Proteins; RNA, Messenger; Simvastatin | 2006 |
Cholestyramine therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. A short-term, double-blind, crossover trial.
Topics: Adult; Aged; Cholesterol, LDL; Cholestyramine Resin; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypercholesterolemia; Lipids; Male; Middle Aged; Risk Factors | 1994 |
Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients.
Topics: Albuminuria; Anticholesteremic Agents; Apolipoproteins; Blood Pressure; Cholesterol, LDL; Cholestyramine Resin; Diabetes Mellitus, Type 2; Female; Glycosaminoglycans; Humans; Hypertension; Male; Middle Aged; Nitrates; Nitrites; Simvastatin | 2000 |
Effects of short-term treatment with diclofenac-colestyramine on renal function and urinary prostanoid excretion in patients with type-2 diabetes.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cholestyramine Resin; Cross-Over Studies; Diabetes Mellitus, Type 2; Diclofenac; Drug Combinations; Female; Glomerular Filtration Rate; Half-Life; Humans; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Prostaglandins; Renal Circulation | 2002 |
5 other study(ies) available for cholestyramine resin and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
In type 2 diabetes induced by cigarette smoking, activation of p38 MAPK is involved in pancreatic β-cell apoptosis.
Topics: Adult; Animals; Apoptosis; Cell Line, Tumor; Cholestyramine Resin; Cigarette Smoking; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Humans; Insulin-Secreting Cells; Male; Mice; p38 Mitogen-Activated Protein Kinases; Smoke | 2018 |
First and only symptom of undiagnosed diabetes mellitus: eruptive xanthoma.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Diabetes Mellitus, Type 2; Female; Gemfibrozil; Humans; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Aspart; Insulin Glargine; Middle Aged; Skin Diseases; Xanthomatosis | 2015 |
Gene expression analysis on the liver of cholestyramine-treated type 2 diabetic model mice.
Topics: Animals; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Diabetes Mellitus, Type 2; Disease Models, Animal; Fatty Liver; Gene Expression Profiling; Hyperinsulinism; Liver; Liver X Receptors; Male; Mice; Oligonucleotide Array Sequence Analysis; Orphan Nuclear Receptors; Phosphoenolpyruvate Carboxykinase (GTP); Reverse Transcriptase Polymerase Chain Reaction; Sterol Regulatory Element Binding Protein 1; Weight Gain | 2010 |
Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin.
Topics: Adipose Tissue; Animals; Anticholesteremic Agents; Blood Glucose; Body Weight; Carrier Proteins; Cholestyramine Resin; Diabetes Mellitus, Type 2; Disease Models, Animal; Epichlorohydrin; Fasting; Fatty Liver; Humans; Hyperlipidemias; Imidazoles; Insulin Resistance; Membrane Glycoproteins; Mice; Obesity; Resins, Synthetic; Weight Gain | 2007 |
Rates of sterol synthesis in the liver and extrahepatic tissues of the SHR/N-corpulent rat, an animal with hyperlipidemia and insulin-independent diabetes.
Topics: Adipose Tissue; Animals; Bile Acids and Salts; Blood Glucose; Cholesterol; Cholestyramine Resin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Energy Intake; Hyperlipidemias; Insulin; Liver; Obesity; Polymers; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Sterols; Succinates; Triglycerides | 1986 |